Dr José Pedro Lavrador, MD is an expert in Neurosurgery at King's College Hospital NHS Foundation Trust (United Kingdom). As of October 2026, ScienceLeadR ranks José Pedro Lavrador in the top 1% of experts in the United Kingdom for Glioma. José Pedro Lavrador has authored 221 publications, the most recent in 2026. SLR score: 721 (community average: 125). How the SLR is computed.

LeadR Profile

Dr José Pedro Lavrador, MD King's College Hospital NHS Foundation Trust United Kingdom
721 ScienceLeadR Reputation 721
Network Map

Neurosurgery

Subspecialties: Neurology - Oncology - Surgery

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2010 - 2026

Source: PubMed

King's College Hospital NHS Foundation Trust

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 221

Citations

Citations: 820 1st author: 45 Last author: 46 Unique author: 0


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Navigated Intraoperative Ultrasound in Functionally Eloquent Tumour Resection: A Descriptive Single-Centre Series Within the Modern Multimodal Neuro-Oncology Surgery Workflow.
PMID 42930791 — glioma, workflow, neoplasm metastasis, neurophysiological monitoring
J Pers Med20260
Functionally Informed Hand Knob Reveals Structural Connectome Differences in Motor-Eloquent Tumours.
PMID 42794892 — connectome, transcranial magnetic stimulation, glioblastoma, basal ganglia, ganglia
Cancers (Basel)20260
nTMS-determined cortical excitability is associated with overall survival in patients with motor-eloquent glioblastoma.
PMID 42776377 — cortical excitability, glioblastoma, nervous system neoplasms
J Neurooncol20260
Anticoagulation and Antiplatelet Therapy in Chronic Subdural Hematoma: A Multicenter Evaluation.
PMID 42554463 — comorbidity, anticoagulants, mortality, hematoma, hematoma, subdural, chronic, hematoma, subdural, reoperation, neurosurgery, odds ratio, therapeutics
Neurosurgery20260
Does pattern of 5-aminolevulinic acid (5-ALA) residual intra-operatively predict worse outcome in glioblastoma?
PMID 42502369 — aminolevulinic acid, glioblastoma
Brain Spine20260

LeadR Networks

Main global connection map